{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:18:35Z","timestamp":1784323115099,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sch\u00f6rling Family Foundation"},{"name":"KTH Center for Applied Precision Medicine"},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JPND Prefrontals Swedish Research Council","award":["529-2014-7504"],"award-info":[{"award-number":["529-2014-7504"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2015-02926"],"award-info":[{"award-number":["2015-02926"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2018-02754"],"award-info":[{"award-number":["2018-02754"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Alzheimer Foundation"},{"name":"Stockholm County Council ALF"},{"name":"Karolinska Institutet Doctoral Funding"},{"name":"StratNeuro, Swedish Demensfonden"},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The clinical presentations of frontotemporal dementia (FTD) are diverse and overlap with other neurological disorders. There are, as of today, no biomarkers in clinical practice for diagnosing the disorders. Here, we aimed to find protein markers in cerebrospinal fluid (CSF) from patients with FTD, presymptomatic mutation carriers and non-carriers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Antibody suspension bead arrays were used to analyse 328 proteins in CSF from patients with behavioural variant FTD (bvFTD,<jats:italic>n<\/jats:italic>\u2009=\u200916) and progressive primary aphasia (PPA,<jats:italic>n<\/jats:italic>\u2009=\u200913), as well as presymptomatic mutation carriers (PMC,<jats:italic>n<\/jats:italic>\u2009=\u200916) and non-carriers (NC,<jats:italic>n<\/jats:italic>\u2009=\u20098). A total of 492 antibodies were used to measure protein levels by direct labelling of the CSF samples. The findings were further examined in an independent cohort including 13 FTD patients, 79 patients with Alzheimer\u2019s disease and 18 healthy controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found significantly altered protein levels in CSF from FTD patients compared to unaffected individuals (PMC and NC) for 26 proteins. The analysis show patterns of separation between unaffected individuals and FTD patients, especially for those with a clinical diagnosis of bvFTD. The most statistically significant differences in protein levels were found for VGF, TN-R, NPTXR, TMEM132D, PDYN and NF-M. Patients with FTD were found to have higher levels of TN-R and NF-M, and lower levels of VGF, NPTXR, TMEM132D and PDYN, compared to unaffected individuals. The main findings were reproduced in the independent cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this pilot study, we show a separation of FTD patients from unaffected individuals based on protein levels in CSF. Further investigation is required to explore the CSF profiles in larger cohorts, but the results presented here has the potential to enable future clinical utilization of these potential biomarkers within FTD.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40035-020-00198-y","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T04:14:48Z","timestamp":1592885688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3908-6476","authenticated-orcid":false,"given":"Julia","family":"Remnest\u00e5l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn","family":"\u00d6ijerstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbe","family":"Ullgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Kultima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ingelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Kilander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Uhl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"M\u00e5nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"198_CR1","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain [Internet] 2011;134(9):2456\u20132477. Available from: https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awr179."},{"key":"198_CR2","doi-asserted-by":"crossref","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurol Int 2011;76(11):1006\u20131014. Available from: http:\/\/www.neurology.org\/cgi\/doi\/10.1212\/WNL.0b013e31821103e6.","DOI":"10.1212\/WNL.0b013e31821103e6"},{"issue":"7","key":"198_CR3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/01.WNL.0000055861.95202.8D","volume":"60","author":"C Lomen-Hoerth","year":"2003","unstructured":"Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60(7):1094\u20137.","journal-title":"Neurology."},{"issue":"10004","key":"198_CR4","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386(10004):1672\u201382.","journal-title":"Lancet."},{"key":"198_CR5","doi-asserted-by":"crossref","unstructured":"Hodges JR, Patterson K, Ward R, Garrard P, Bak T, Perry R, et al. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer\u2019s disease: a comparative neuropsychological study. Neuropsychology. 1999;13(1);31\u201340.","DOI":"10.1037\/0894-4105.13.1.31"},{"key":"198_CR6","doi-asserted-by":"crossref","unstructured":"Rohrer JD, Beck J, Isaacs AM, Authier A, Warren JD, Mead S. The heritability and genetics of frontotemporal lobar degeneration 2009;1451\u20131456.","DOI":"10.1212\/WNL.0b013e3181bf997a"},{"issue":"6686","key":"198_CR7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702\u20135 Available from: http:\/\/www.nature.com\/articles\/31508.","journal-title":"Nature."},{"issue":"7105","key":"198_CR8","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature [Internet]. 2006;442(7105):916\u20139 Available from: http:\/\/www.nature.com\/articles\/nature05016.","journal-title":"Nature [Internet]"},{"issue":"7105","key":"198_CR9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nature05017","volume":"442","author":"M Cruts","year":"2006","unstructured":"Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920\u20134 Available from: http:\/\/www.nature.com\/articles\/nature05017.","journal-title":"Nature."},{"issue":"2","key":"198_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC Hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245\u201356 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627311008282.","journal-title":"Neuron"},{"issue":"2","key":"198_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Sim\u00f3n-S\u00e1nchez J, Rollinson S, Gibbs JR, et al. A Hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257\u201368 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627311007975.","journal-title":"Neuron"},{"key":"198_CR12","doi-asserted-by":"crossref","unstructured":"O\u0308ijerstedt L, Chiang H-H, Bjo\u0308rkstro\u0308m J, Forsell C, Lilius L, Lindstro\u0308m A-K, et al. Confirmation of high frequency of C9orf72 mutations in patients with frontotemporal dementia from Sweden. Neurobiol Aging [Internet]. 2019;84:241.e21-241.e25. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019300879. Cited 4 Sep 2019.","DOI":"10.1016\/j.neurobiolaging.2019.03.009"},{"key":"198_CR13","unstructured":"van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Engelborghs S, et al. A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat. 2013 Feb [cited 2018 Jun 6];34(2):363\u2013373. Available from: http:\/\/doi.wiley.com\/10.1002\/humu.22244."},{"key":"198_CR14","doi-asserted-by":"crossref","unstructured":"Van Mossevelde S, Engelborghs S, van der Zee J, Van Broeckhoven C. Genotype-phenotype links in frontotemporal lobar degeneration. Nat Rev Neurol 2018 18 [cited 2019 Mar 26];14(6):363\u2013378. Available from: http:\/\/www.nature.com\/articles\/s41582-018-0009-8.","DOI":"10.1038\/s41582-018-0009-8"},{"issue":"1","key":"198_CR15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.24052","volume":"75","author":"CS Scherling","year":"2014","unstructured":"Scherling CS, Hall T, Berisha F, Klepac K, Karydas A, Coppola G, et al. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol. 2014;75(1):116\u201326.","journal-title":"Ann Neurol"},{"issue":"7","key":"198_CR16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrneurol.2017.75","volume":"13","author":"LH Meeter","year":"2017","unstructured":"Meeter LH, Kaat LD, Rohrer JD, Van Swieten JC. Imaging and fluid biomarkers in frontotemporal dementia. Nat Rev Neurol. 2017;13(7):406\u201319.","journal-title":"Nat Rev Neurol"},{"issue":"23","key":"198_CR17","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e318200d78d","volume":"75","author":"WT Hu","year":"2010","unstructured":"Hu WT, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, et al. Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology. 2010;75(23):2079\u201386.","journal-title":"Neurology."},{"issue":"2","key":"198_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JAD-160366","volume":"55","author":"A Rivero-Santana","year":"2017","unstructured":"Rivero-Santana A, Ferreira D, Perestelo-Perez L, Westman E, Wahlund L-O, Sarria A, et al. Cerebrospinal fluid biomarkers for the differential diagnosis between Alzheimer\u2019s disease and Frontotemporal lobar degeneration: systematic review, HSROC analysis, and confounding factors. J Alzheimers Dis. 2017;55(2):625\u201344.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"198_CR19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/acn3.325","volume":"3","author":"LH Meeter","year":"2016","unstructured":"Meeter LH, Dopper EG, Jiskoot LC, Sanchez-Valle R, Graff C, Benussi L, et al. Neurofilament light chain: a biomarker for genetic frontotemporal dementia. Ann Clin Transl Neurol. 2016 Aug;3(8):623\u201336.","journal-title":"Ann Clin Transl Neurol"},{"issue":"21","key":"198_CR20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","volume":"83","author":"T Skillback","year":"2014","unstructured":"Skillback T, Farahmand B, Bartlett JW, Rosen C, Mattsson N, Nagga K, et al. CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival. Neurology. 2014;83(21):1945\u201353.","journal-title":"Neurology."},{"issue":"9","key":"198_CR21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, Alvarez-Cerme\u00f1o JC, et al. Diagnostic value of cerebrospinal fluid Neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76(9):1035\u201348.","journal-title":"JAMA Neurol"},{"key":"198_CR22","doi-asserted-by":"crossref","unstructured":"Rohrer JD, Warren JD, Fox NC, Rossor MN. Presymptomatic studies in genetic frontotemporal dementia. Revue Neurologique (Paris); 2013;169(10):820-4.","DOI":"10.1016\/j.neurol.2013.07.010"},{"issue":"14)","key":"198_CR23","first-page":"1","volume":"4422","author":"JD Rohrer","year":"2015","unstructured":"Rohrer JD, Nicholas JM, Cash DM, Van SJ, Dopper E, Jiskoot L, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative ( GENFI ) study. Cross-Sectional Anal. 2015;4422(14)):1\u201310.","journal-title":"Cross-Sectional Anal"},{"key":"198_CR24","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1021\/pr700890b","volume":"7","author":"JM Schwenk","year":"2008","unstructured":"Schwenk JM, Gry M, Rimini R, Uhl\u00e9n M, Nilsson P. Antibody suspension bead arrays \u2013 an application for serum and plasma analysis within antibody proteomics. J Proteome Res. 2008;7:3168\u201379.","journal-title":"J Proteome Res"},{"key":"198_CR25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-9706-0_19","volume":"2044","author":"E Pin","year":"2019","unstructured":"Pin E, Sjoberg R, Andersson E, Hellstrom C, Olofsson J, Jernbom Falk A, et al. Array-based profiling of proteins and autoantibody repertoires in CSF. Methods Mol Biol. 2019;2044:303\u201318.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"198_CR26","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/prca.201500150","volume":"10","author":"J Remnest\u00e5l","year":"2016","unstructured":"Remnest\u00e5l J, Just D, Mitsios N, Fredolini C, Mulder J, Schwenk JM, et al. CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer\u2019s disease. Proteomics - Clin Appl. 2016;10(12):1242\u201353.","journal-title":"Proteomics - Clin Appl"},{"issue":"15","key":"198_CR27","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/pmic.201200580","volume":"13","author":"A H\u00e4ggmark","year":"2013","unstructured":"H\u00e4ggmark A, Bystr\u00f6m S, Ayoglu B, Qundos U, Uhl\u00e9n M, Khademi M, et al. Antibody-based profiling of cerebrospinal fluid within multiple sclerosis. Proteomics. 2013;13(15):2256\u201367.","journal-title":"Proteomics."},{"issue":"15","key":"198_CR28","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201900008","volume":"19","author":"RS Haussler","year":"2019","unstructured":"Haussler RS, Bendes A, Iglesias M, Sanchez-Rivera L, Dodig-Crnkovic T, Bystrom S, et al. Systematic development of Sandwich immunoassays for the plasma Secretome. Proteomics. 2019 Aug;19(15):e1900008.","journal-title":"Proteomics"},{"key":"198_CR29","volume-title":"R Foundation For Statistical Computing [Internet]","author":"R Core","year":"2018","unstructured":"Core R, Team R. A language and environment for statistical computing. In: R Foundation For Statistical Computing [Internet]. Vienna, Austria: R Foundation For Statistical Computing; 2018. Available from: https:\/\/www.r-project.org\/."},{"key":"198_CR30","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289\u2013300.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"198_CR31","doi-asserted-by":"crossref","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited alzheimer\u2019s disease. N Engl J Med. 2012;367(9);795\u2013804.","DOI":"10.1056\/NEJMoa1202753"},{"issue":"42","key":"198_CR32","doi-asserted-by":"crossref","first-page":"13377","DOI":"10.1523\/JNEUROSCI.1127-09.2009","volume":"29","author":"MS Riedl","year":"2009","unstructured":"Riedl MS, Braun PD, Kitto KF, Roiko SA, Anderson LB, Honda CN, et al. Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing. J Neurosci. 2009;29(42):13377\u201388.","journal-title":"J Neurosci"},{"issue":"44","key":"198_CR33","doi-asserted-by":"crossref","first-page":"15388","DOI":"10.1523\/JNEUROSCI.0293-12.2012","volume":"32","author":"H Sato","year":"2012","unstructured":"Sato H, Fukutani Y, Yamamoto Y, Tatara E, Takemoto M, Shimamura K, et al. Thalamus-derived molecules promote survival and dendritic growth of developing cortical neurons. J Neurosci. 2012;32(44):15388\u2013402.","journal-title":"J Neurosci"},{"issue":"4","key":"198_CR34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/acn3.745","volume":"6","author":"EL van der Ende","year":"2019","unstructured":"van der Ende EL, Meeter LH, Stingl C, van Rooij JGJ, Stoop MP, Nijholt DAT, et al. Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics. Ann Clin Transl Neurol. 2019;6(4):698\u2013707.","journal-title":"Ann Clin Transl Neurol."},{"issue":"2","key":"198_CR35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.expneurol.2005.08.002","volume":"196","author":"U R\u00fcetschi","year":"2005","unstructured":"R\u00fcetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, et al. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp Neurol. 2005;196(2):273\u201381.","journal-title":"Exp Neurol"},{"issue":"2","key":"198_CR36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3233\/JAD-180855","volume":"67","author":"PE Khoonsari","year":"2019","unstructured":"Khoonsari PE, Shevchenko G, Herman S, Remnestal J, Giedraitis V, Brundin R, et al. Improved differential diagnosis of Alzheimer\u2019s disease by integrating ELISA and Mass spectrometry-based cerebrospinal fluid biomarkers. J Alzheimers Dis. 2019;67(2):639\u201351.","journal-title":"J Alzheimers Dis"},{"key":"198_CR37","doi-asserted-by":"crossref","unstructured":"Duits FH, Brinkmalm G, Teunissen CE, Brinkmalm A, Scheltens P, Van der Flier WM, et al. Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer\u2019s disease. Alzheimers Res Ther. 2018 15;10(1):5. Available from: https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-017-0335-x.","DOI":"10.1186\/s13195-017-0335-x"},{"key":"198_CR38","doi-asserted-by":"crossref","unstructured":"Brinkmalm G, Sjodin S, Simonsen AH, Hasselbalch SG, Zetterberg H, Brinkmalm A, et al. A parallel reaction monitoring mass spectrometric method for analysis of potential CSF biomarkers for alzheimer\u2019s disease. Proteomics Clin Appl. 2018;12(1);1700131:1\u201313.","DOI":"10.1002\/prca.201700131"},{"issue":"8","key":"198_CR39","doi-asserted-by":"crossref","first-page":"e0135365","DOI":"10.1371\/journal.pone.0135365","volume":"10","author":"RC Hendrickson","year":"2015","unstructured":"Hendrickson RC, Lee AYH, Song Q, Liaw A, Wiener M, Paweletz CP, et al. High resolution discovery proteomics reveals candidate disease progression markers of Alzheimer\u2019s disease in human cerebrospinal fluid. PLoS One. 2015;10(8):e0135365.","journal-title":"PLoS One"},{"issue":"6","key":"198_CR40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1460-9568.2008.06108.x","volume":"27","author":"CM Galtrey","year":"2008","unstructured":"Galtrey CM, Kwok JCF, Carulli D, Rhodes KE, Fawcett JW. Distribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cord. Eur J Neurosci. 2008;27(6):1373\u201390.","journal-title":"Eur J Neurosci"},{"issue":"4","key":"198_CR41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1014452212067","volume":"30","author":"ES Wintergerst","year":"2001","unstructured":"Wintergerst ES, Rathjen FG, Schwaller B, Eggli P, Celio MR. Tenascin-R associates extracellularly with parvalbumin immunoreactive neurones but is synthesised by another neuronal population in the adult rat cerebral cortex. J Neurocytol. 2001;30(4):293\u2013301.","journal-title":"J Neurocytol"},{"issue":"2","key":"198_CR42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0306-4522(01)00082-3","volume":"104","author":"O Bukalo","year":"2001","unstructured":"Bukalo O, Schachner M, Dityatev A. Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience. 2001;104(2):359\u201369.","journal-title":"Neuroscience."},{"issue":"1","key":"198_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1097-4547(20000401)60:1<21::AID-JNR3>3.0.CO;2-H","volume":"60","author":"R Probstmeier","year":"2000","unstructured":"Probstmeier R, Stichel CC, Muller HW, Asou H, Pesheva P. Chondroitin sulfates expressed on oligodendrocyte-derived tenascin-R are involved in neural cell recognition. Functional implications during CNS development and regeneration. J Neurosci Res. 2000;60(1):21\u201336.","journal-title":"J Neurosci Res"},{"key":"198_CR44","doi-asserted-by":"publisher","unstructured":"Manavalan A, Mishra M, Feng L, Sze SK, Akatsu H, Heese K. Brain site-specific proteome changes in aging-related dementia. Exp Mol Med [Internet] 2013;45(9):e39\u2013e17. Available from: https:\/\/doi.org\/10.1038\/emm.2013.76.","DOI":"10.1038\/emm.2013.76"},{"issue":"1\u20132","key":"198_CR45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-4328(03)00109-8","volume":"145","author":"S Freitag","year":"2003","unstructured":"Freitag S, Schachner M, Morellini F. Behavioral alterations in mice deficient for the extracellular matrix glycoprotein tenascin-R. Behav Brain Res. 2003;145(1\u20132):189\u2013207.","journal-title":"Behav Brain Res"},{"issue":"1","key":"198_CR46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1601-183X.2003.00003.x","volume":"2","author":"M Montag-Sallaz","year":"2003","unstructured":"Montag-Sallaz M, Montag D. Severe cognitive and motor coordination deficits in tenascin-R-deficient mice. Genes, Brain Behav. 2003;2(1):20\u201331.","journal-title":"Genes, Brain Behav"},{"key":"198_CR47","doi-asserted-by":"crossref","unstructured":"Yuan A, Rao MV, Veeranna, Nixon RA. Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol. 2017;9(4);a018309:1\u201324.","DOI":"10.1101\/cshperspect.a018309"},{"key":"198_CR48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1359-0294(03)00010-4","volume":"8","author":"PA Janmey","year":"2003","unstructured":"Janmey PA, Leterrier JF, Herrmann H. Assembly and structure of neurofilaments. Curr Opin Colloid Interface Sci. 2003;8:145\u201355.","journal-title":"Curr Opin Colloid Interface Sci"},{"issue":"10","key":"198_CR49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"T Gattringer","year":"2018","unstructured":"Gattringer T, Otto M, Teunissen CE, Comabella M, Blennow K, Kuhle J, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577\u201389.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"198_CR50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-019-02093-x","volume":"139","author":"P Oeckl","year":"2020","unstructured":"Oeckl P, Weydt P, Thal DR, Weishaupt JH, Ludolph AC, Otto M. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP 2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Acta Neuropathol. 2020;139(1):119\u201334.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"198_CR51","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1515\/cclm-2014-0908","volume":"53","author":"E Martinez-Morillo","year":"2015","unstructured":"Martinez-Morillo E, Childs C, Garcia BP, Alvarez Menendez FV, Romaschin AD, Cervellin G, et al. Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury. Clin Chem Lab Med. 2015 Sep;53(10):1575\u201384.","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"198_CR52","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/acn3.83","volume":"1","author":"A H\u00e4ggmark","year":"2014","unstructured":"H\u00e4ggmark A, Mikus M, Mohsenchian A, Hong M-G, Forsstrom B, Gajewska B, et al. Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2014 Aug;1(8):544\u201353.","journal-title":"Ann Clin Transl Neurol."},{"key":"198_CR53","unstructured":"The Human Protein Atlas. NPTXR Tissue Expression [Internet]. Available from: https:\/\/www.proteinatlas.org\/ENSG00000221890-NPTXR\/tissue. Cited 16 Jan 2020."},{"key":"198_CR54","unstructured":"The Human Protein Atlas. TMEM132D Tissue Expression [Internet]. Available from: https:\/\/www.proteinatlas.org\/ENSG00000151952-TMEM132D\/tissue. Cited 16 Jan 2020."},{"issue":"2","key":"198_CR55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jb\/mvg135","volume":"134","author":"H Nomoto","year":"2003","unstructured":"Nomoto H, Yonezawa T, Itoh K, Ono K, Yamamoto K, Oohashi T, et al. Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes. J Biochem. 2003;134(2):231\u20138.","journal-title":"J Biochem"},{"issue":"5","key":"198_CR56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/bioinformatics\/btx689","volume":"34","author":"L Sanchez-Pulido","year":"2018","unstructured":"Sanchez-Pulido L, Ponting CP. TMEM132: an ancient architecture of cohesin and immunoglobulin domains define a new family of neural adhesion molecules. Bioinformatics. 2018;34(5):721\u20134.","journal-title":"Bioinformatics."},{"issue":"9","key":"198_CR57","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1038\/tp.2012.85","volume":"2","author":"A Erhardt","year":"2012","unstructured":"Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, M\u00fcller-Myhsok B, et al. Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry. 2012;2(9):e156 [cited 2019 Sep 4] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22948381.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"198_CR58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pharmthera.2009.05.006","volume":"123","author":"C Schwarzer","year":"2009","unstructured":"Schwarzer C. 30 years of dynorphins--new insights on their functions in neuropsychiatric diseases. Pharmacol Ther. 2009;123(3):353\u201370.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"198_CR59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00702-009-0238-5","volume":"116","author":"H Kolsch","year":"2009","unstructured":"Kolsch H, Wagner M, Bilkei-Gorzo A, Toliat MR, Pentzek M, Fuchs A, et al. Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly. J Neural Transm. 2009;116(7):897\u2013903.","journal-title":"J Neural Transm"},{"issue":"3","key":"198_CR60","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00415-012-6721-1","volume":"260","author":"K Fawcett","year":"2013","unstructured":"Fawcett K, Mehrabian M, Liu Y-T, Hamed S, Elahi E, Revesz T, et al. The frequency of spinocerebellar ataxia type 23 in a UK population. J Neurol. 2013;260(3):856\u20139.","journal-title":"J Neurol"},{"issue":"11","key":"198_CR61","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.neurobiolaging.2006.07.002","volume":"28","author":"T Yakovleva","year":"2007","unstructured":"Yakovleva T, Marinova Z, Kuzmin A, Seidah NG, Haroutunian V, Terenius L, et al. Dysregulation of dynorphins in Alzheimer disease. Neurobiol Aging. 2007;28(11):1700\u20138.","journal-title":"Neurobiol Aging"},{"issue":"2\u20133","key":"198_CR62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000353848","volume":"13","author":"C Menard","year":"2014","unstructured":"Menard C, Herzog H, Schwarzer C, Quirion R. Possible role of dynorphins in Alzheimer\u2019s disease and age-related cognitive deficits. Neurodegener Dis. 2014;13(2\u20133):82\u20135.","journal-title":"Neurodegener Dis"},{"key":"198_CR63","doi-asserted-by":"publisher","unstructured":"Chen CPC, Chen RL, Preston JE. The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma. Exp Gerontol [Internet] 2012;47(4):323\u2013328. Available from: https:\/\/doi.org\/10.1016\/j.exger.2012.01.008.","DOI":"10.1016\/j.exger.2012.01.008"},{"issue":"2","key":"198_CR64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neurobiolaging.2004.03.012","volume":"26","author":"J Zhang","year":"2005","unstructured":"Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, et al. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol Aging. 2005;26(2):207\u201327.","journal-title":"Neurobiol Aging"},{"key":"198_CR65","doi-asserted-by":"publisher","unstructured":"Baird GS, Nelson SK, Keeney TR, Stewart A, Williams S, Kraemer S, et al. Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array. Am J Pathol 2012;180(2):446\u2013456. Available from: https:\/\/doi.org\/10.1016\/j.ajpath.2011.10.024.","DOI":"10.1016\/j.ajpath.2011.10.024"},{"key":"198_CR66","doi-asserted-by":"publisher","unstructured":"Andersson A, Remnest\u00e5l J, Nellg\u00e5rd B, Vunk H, Kotol D, Edfors F, et al. Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer\u2019s disease. Clin Chim Acta . 2019;494(march):79\u201393. Available from: https:\/\/doi.org\/10.1016\/j.cca.2019.03.243.","DOI":"10.1016\/j.cca.2019.03.243"},{"key":"198_CR67","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jprot.2013.04.020","volume":"95","author":"U Qundos","year":"2013","unstructured":"Qundos U, Hong MG, Tybring G, Divers M, Odeberg J, Uhlen M, et al. Profiling post-centrifugation delay of serum and plasma with antibody bead arrays. J Proteomics [Internet]. 2013;95:46\u201354. Available from: https:\/\/doi.org\/10.1016\/j.jprot.2013.04.020.","journal-title":"J Proteomics [Internet]"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-020-00198-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-020-00198-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-020-00198-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T22:01:45Z","timestamp":1667080905000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-020-00198-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1186\/s40035-020-00198-y","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Ethical Review Board, Stockholm, Sweden (registration numbers: 2017\/834\u201331\/1, 2012\/1611\u201331\/3, 2013\/1563\u201332, 2017\/2097\u201332) and the Regional Ethical Review Board in Uppsala, Sweden (registration numbers: 2005\u2013244, \u00d6 48\u20132005; 2005-11-02, 2006-01-30, 2011\/044; 2011-02-23).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest relevant to the work conducted in the presented study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}